Category Archives: Business and Investments

Latest From Business and Investments

Is the early-stage IPO making a comeback?

Yesterday was the NASDAQ debut for preclinical-stage biotech Regulus (RGLS). The microRNA platform company is working in multiple therapeutic areas and planning to reach the clinic in 2014. Since the start of the 2009 post-market crash window for biotech IPOs, there have been only two preclinical biotech companies to make it to the public stage. Back in January, we saw Verastem (VSTM), at only 1.5 years of age, make it to the NASDAQ and raise Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post

#BIF2012 Company Snapshot: Profil Institute for Translational Medicine

profil_trans_med

For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of the presenting companies at the event, Profil Institute for Translational Medicine, Inc. To find out more about this organization and what they’re doing for biotech, please read below! You’ll be able to see their presentation onsite, Wednesday 10/10 at 9:30am in the Presidio Room.   Company Snapshot What is your company’s lead product or technology? Based on collaborations with biopharma, Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Virginia Bio Announces New Executive Leadership

JeffGallagher2

The Virginia Biotechnology Association (Virginia Bio), the premier statewide non-profit trade association for life science industries, has named its interim executive director to the full-time position of chief executive officer. With an extensive background in the law and non-profit sectors as well as the life sciences, Jeffrey Gallagher brings leadership and policy expertise to his newly defined role, where he will be responsible for developing and executing the association’s strategic plans, prioritizing the organization’s areas Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

A Start-Up Model Worthy of Consideration

attendessBusinessForum

Biotech LLCs are getting a lot of attention lately, and perhaps rightfully so. The Wall Street Journal’s Brian Gormley recently talked to Albert L. Sokol, a partner with Edwards Wildman Palmer, about the two venture-backed biotechs – Forma Therapeutics and Viamet Pharmaceuticals – that he helped convert to LLCs. In the WSJ article – Biotech Start-Ups See Benefits from Changing Structure, Lawyer Says – Sokol describes the benefits to start-ups and their venture investors, as Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2012 BIO Investor Forum: Discovery Track Snapshot

cablecar

BIO’s 11th Annual BIO Investor Forum is just around the corner – it will be held October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The forum, or BIF as we call it around here, is an international investor event which explores trends and opportunities in life sciences. Broadly speaking, the focus is on venture-stage growth and emerging public companies. BIO’s Alan Eisenberg said it best earlier this week: “The aim of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,